Place of Origin: | China |
---|---|
Brand Name: | Senwayer Brand |
Certification: | ISO, 9001, USP |
Model Number: | 184475-35-2 |
Minimum Order Quantity: | 10grams |
Price: | Discount is possible if your order is big enough |
Packaging Details: | 10g, 20g, 50g , 100g, 500g. 1kg, 10kg |
Delivery Time: | within 2 working days |
Payment Terms: | T/T in advance, Money Gram, Western Union, Bank Transfer. |
Supply Ability: | 1000kg/month |
CAS: | 184475-35-2 | Apparence: | Almost White Crystalline Powder |
---|---|---|---|
Purity: | 99% | Other Name: | N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine |
MF: | C22H24ClFN4O3 | MW: | 446.9 |
EINECS: | 643-034-7 | Usage: | Antitumor |
High Light: | anti cancer drugs,antineoplastic drugs |
Medical Effective Gefitinib Iressa Cancer Treating Raw Material Powder 184475-35-2
Quick detail
Product Name: Gefitinib
Synonyms: IRESSA;GEFITINIB;AKOS 91371;n-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine;N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine;ZD 1839;4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-;Gefitinib(TINIBS)
CAS: 184475-35-2
MF: C22H24ClFN4O3
MW: 446.9
Product Categories: Active Pharmaceutical Ingredients;Gefitinib;Molecular Targeted Antineoplastic;Intermediates & Fine Chemicals;Pharmaceuticals;Pharmaceutical intermediate;APIs;IRESSA;Anti-cancer&immunity;API;Inhibitors
Recommended Antineoplastic products
Lapatinib | CAS : 231277-92-2 | Cisplatin | 15663-27-1 |
Dasatinib | 302962-49-8 | Vincristine sulfate | 2068-78-2 |
Axitinib | 319460-85-0 | Melphalan | 148-82-3 |
Gefitinib | 184475-35-2 | Nimustine hydrochloride | 55661-38-6 |
Sunitinib Malate | 341031-54-7 | Gemcitabine | 95058-81-4 |
Erlotinib hydrochloride | 183319-69-9 107868-30-4 | Paclitaxel | 33069-62-4 |
Doxorubicin hydrochloride | 25316-40-9 | Docetaxel | 114977-28-5 |
Mitomycin C | 50-07-7 | (Podophyllotoxin)nsc24818 | 518-28-5 Recommended Antineoplastic products: |
Tegafur | 17902-23-7 |
Gefitinib Description :
Gefitinib (ZD1839) (INN, , trade name Iressa, marketed by AstraZeneca and Teva), is a drug used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and overactive EGFR. However, meta-analyses have not shown any improvement in overall survival, that is, it does not extend life.
Gefitinib is used to treat non-small cell lung cancer that has spread to other parts of the body in people with certain types of tumors. Gefitinib is in a class of medications called kinase inhibitors. It works by blocking the action of a certain naturally occurring substance that may be needed to help cancer cells multiply.
How you have Gefitinib :
Gefitinib comes as a tablet to take by mouth. It is usually taken with or without food once a day. Take gefitinib at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take gefitinib exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
If you are unable to swallow the tablets, you may dissolve them in water. Place one tablet in 4 to 8 ounces (120 to 240 mL) of plain, noncarbonated drinking water. Stir with a spoon for about 15 minutes until the tablet is dissolved. Drink the mixture right away. Rinse the glass with another 4 to 8 ounces (120 to 240 mL) of water and drink the rinse water right away to be sure that you swallow all of the medication.
Your doctor may delay or permanently stop your treatment if you experience certain side effects. Be sure to tell your doctor how you are feeling during your treatment with gefitinib.
What special precautions should I follow?
Before taking gefitinib,
Gefitinib COA
Tests | Specification | Results |
Appearance | Slight white to white crystalline powder | White crystalline powder |
Identification IR(1) | Conforms to the refence | Conforms to the refence |
Melting Point | 194.0~198.0°C | 196.0~197.0°C |
Water(KF) | ≤0.30% | 0.05% |
Assay (HPLC) | ≥99.0% | 99.9% |
Individual Purity (HPLC ) | ≤0.20% | 0.09% |
Conclusion | Conform with company standard |